Discover the importance of adult vaccination in India, the barriers faced, and the urgent need for prioritization.

Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its price target lowered by Jefferies Financial Group from $70.00 to $53.00 in a research report report published on Tuesday,Benzinga reports.

PDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...

Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) gapped down prior to trading on Monday after HC Wainwright lowered their price target on the stock from $11.00 to $10.00. The stock had ...

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...

A dividend from immunisation is a future free from the diseases that rob communities of health and well-being, a future free ...

It’s a question I have asked myself too many times. I know the insecurity festering within it. I also know how much life I ...

Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

We are thrilled to share that the first trial site has been initiated and activation of additional clinical sites continues,” said Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS ...

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...

The dawn of a new era featuring a heavy nod to the past, West Coast’s 2025 season launch on Thursday morning promised progress and improvement.

Limited or Ligand Pharmaceuticals Incorporated is a better investment based on AAII's A+ Investor grades, which compare both ...